Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan

References

• Pfaller MA, Jones RN, Messer SA, et al. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis 1998; 30: 121–129
   PubMed Web of Science ®Google Scholar
• Chen YC, Chang SC, Sun CC, et al. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997; 18: 369–375
   Google Scholar
• Cheng MF, Yu KW, Tang RB, et al. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 2004; 48: 33–37
   PubMedGoogle Scholar
• Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000; 44: 747–751
   PubMed Web of Science ®Google Scholar
• Yang YL, Ho YA, Cheng HH, et al. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 2004; 25: 60–64
   PubMed Web of Science ®Google Scholar
• Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73–85
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10(Suppl. 1)48–66
   PubMed Web of Science ®Google Scholar
• Hadfield TL, Smith MB, Winn RE, et al. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987; 9: 1006–1012
   PubMedGoogle Scholar
• Orozco AS, Higginbotham LM, Hitchcock CA, et al. Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chemother 1998; 42: 2645–2649
   PubMed Web of Science ®Google Scholar
• Voss A, Hollis RJ, Pfaller MA, et al. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994; 32: 975–980
   PubMed Web of Science ®Google Scholar
• Cheng MF, Yang YL, Yao TJ, et al. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis 2005; 5: 22
   PubMedGoogle Scholar
• Peman J, Canton E, Gobernado M. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2005; 24: 23–30
   PubMed Web of Science ®Google Scholar
• Yang YL, Li SY, Cheng HH, Lo HJ. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis 2005; 51: 179–183
   PubMed Web of Science ®Google Scholar
• Lo HJ, Ho AH, Ho M. Factors accounting for mis-identification of Candida species. J Microbiol Immunol Infect 2001; 34: 171–177
   PubMedGoogle Scholar
• Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329–334
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (formerly NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27A 1997.
   Google Scholar
• Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999; 33: 217–222
   PubMed Web of Science ®Google Scholar
• Edwards EJJ. Candida species. Principles and Practice of Infectious Diseases, GL Mandell, RG Douglas, JE Bennett. Churchill Livingstone, New York 1990; 1943–1958
   Google Scholar
• Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243–260
   PubMed Web of Science ®Google Scholar
• Voss A, Kluytmans JA, Koeleman JG, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 909–912
   PubMed Web of Science ®Google Scholar
• Abi-Said D, Anaissie E, Uzun O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–1128
   PubMed Web of Science ®Google Scholar
• Levin AS, Costa SF, Mussi NS, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis 1998; 30: 243–249
   PubMed Web of Science ®Google Scholar
• Hedderwick SA, Lyons MJ, Liu M, et al. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 2000; 19: 663–670
   PubMed Web of Science ®Google Scholar
• Viudes A, Peman J, Canton E, et al. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002; 21: 767–774
   PubMed Web of Science ®Google Scholar